Explorer›Medicine›Open Science
Research PaperResearchia:202602.16034

Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial

Tom Solomon

Abstract

Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial --- Source: OpenAlex - The Lancet Neurology (Citations: 1) PDF: https://doi.org/10.1016/s1474-4422(25)00454-5 Original Link: https://doi.org/https://doi.org/10.1016/s1474-4422(25)00454-5

Submitted: February 16, 2026Subjects: Open Science; Medicine

Description / Details

Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial

Source: OpenAlex - The Lancet Neurology (Citations: 1) PDF: https://doi.org/10.1016/s1474-4422(25)00454-5 Original Link: https://doi.org/https://doi.org/10.1016/s1474-4422(25)00454-5

Please sign in to join the discussion.

No comments yet. Be the first to share your thoughts!

Access Paper
View Source PDF
Submission Info
Date:
Feb 16, 2026
Topic:
Medicine
Area:
Open Science
Comments:
0
Bookmark
Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial | Researchia